When we discuss treating acne through the microbiome, most of the clinical attention lands on what we remove. Antibiotics suppress C. acnes proliferation. Benzoyl peroxide eliminates it, along with most other organisms on the skin surface. These remain appropriate first-line interventions for defined clinical presentations.
But the more interesting question for aesthetic practice is a different one. What can we selectively support?
How the terminology has settled
Probiotics, prebiotics, and postbiotics have clear formal definitions now. The International Scientific Association of Probiotics and Prebiotics published a consensus definition for postbiotics in 2021: a postbiotic is a preparation of inactivated microorganisms or their components that confers a health benefit. That includes bacterial lysates, fermented ingredients, and cell wall fragments. The ingredient contains no live organisms. It contains metabolites and structural components that retain biological activity.
Prebiotics are substrates that selectively feed specific beneficial organisms. In skincare, this typically means polysaccharides such as inulin, fructooligosaccharides, and beta-glucan. These feed commensal bacteria rather than C. acnes.
Understanding these distinctions matters in clinical practice. A product labelled "probiotic skincare" may contain postbiotics, not live cultures. The mechanism and evidence base for each category differ.
Why microbiome composition matters in acne
The skin microbiome in acne-prone skin is not simply overloaded with C. acnes. The composition is shifted. Research published in the Journal of Investigative Dermatology demonstrated that different phylotypes of C. acnes are associated with different skin states. Phylotype IA1 is more prevalent in acne-affected skin. Phylotype II is more prevalent in healthy skin. The organism is present in both groups. The population balance determines the clinical picture.
The implication is that acne treatment does not need to eliminate C. acnes entirely. It needs to shift the population toward less inflammatory strains. Broad-spectrum antimicrobial interventions, while effective in the short term, do not discriminate between phylotypes. They reduce total bacterial burden without addressing the distribution.
This is the theoretical basis for microbiome-aware approaches in acne. The goal is a follicular environment where commensal organisms can compete effectively and inflammatory C. acnes strains are less able to dominate.
What prebiotic ingredients do in acne formulations
Prebiotic skincare ingredients selectively feed commensal bacteria. Staphylococcus epidermidis, one of the most abundant organisms in healthy skin, produces short-chain fatty acids that acidify the follicular environment. These SCFAs are directly inhibitory to inflammatory C. acnes strains. A formulation that supports S. epidermidis creates conditions less favourable to inflammatory acne pathogenesis.
Beta-glucan has direct anti-inflammatory properties alongside its prebiotic activity. At relevant concentrations it interacts with toll-like receptors and has been studied in wound healing and barrier repair contexts. In acne-prone skin where barrier compromise is common, this dual action is clinically relevant.
Fructooligosaccharides are fermented by commensal bacteria to produce butyrate, an SCFA with anti-inflammatory signalling properties. The skin evidence is less developed than the gut research in this area, but the receptor pathways are present in skin tissue.
What postbiotic ingredients offer
Lactobacillus ferment lysate is the most common postbiotic ingredient appearing in acne-focused skincare. It contains cell wall fragments and metabolic products from inactivated Lactobacillus species. These components interact with keratinocytes and local immune cells. The proposed mechanism includes modulation of the inflammatory response without introducing live organisms, which makes the ingredient more stable in formulation and predictable in application.
Saccharomyces ferment filtrate, derived from yeast fermentation, contains amino acids, vitamins, and metabolites that have been associated with antimicrobial and sebum-regulating activity in early research.
The clinical evidence for topical postbiotics in acne is at an early stage. Small trials have shown reductions in inflammatory lesion counts when postbiotic ingredients are used alongside standard treatment. Large randomised controlled trials are lacking. Aesthetic practitioners should be honest with patients about this: the mechanism is plausible and early findings are encouraging, but these ingredients are an adjunct to, not a replacement for, first-line acne management.
Where this fits into the consultation
Microbiome-aware skincare sits alongside standard treatment, not in place of it. NICE guideline NG198 remains the clinical reference for acne management in UK practice. Benzoyl peroxide, topical retinoids, and antibiotic combinations with appropriate resistance precautions remain first-line.
Where a patient is using benzoyl peroxide or completing a topical antibiotic course, prebiotic and postbiotic ingredients in the cleansing and moisturising steps may reduce the collateral disruption to commensal populations. Benzoyl peroxide is non-selective. Pairing it with something that actively supports beneficial flora is a coherent approach, even if the evidence for the combination is preliminary.
In consultation, I advise patients to look for formulations with a short ingredient list, clearly identified prebiotic or postbiotic actives, and without fragrance or known irritants that would further destabilise the skin microbiome. A compromised barrier and a disrupted microbiome compound each other. Both need to be addressed.
For a structured clinical framework for acne consultation, treatment protocol design, and the role of skincare in microbiome management, Acne Decoded covers the evidence in full at aestheticsunlocked.co.uk/courses/acne-decoded.